Immunogenic cell death (ICD) plays a major role in providing long lasting protective
antitumor immunity by the chronic exposure of damage associated molecular patterns …

The purpose of this study was the overview of current knowledge regarding the use of
survivin and its isoforms in prognosis and treatment of breast cancer. An advanced search of …

Drug resistance is a major hurdle for successful treatment of breast cancer, the leading
cause of deaths in women throughout the world. The FOXM1 transcription factor is a potent …

The combination of natural products with standard chemotherapeutic agents offers a
promising strategy to enhance the efficacy or reduce the side effects of standard …

Long treatment with paclitaxel (PTX) might increase resistance and side-effects causing a
failure in cancer chemotherapy. Here we uncovered that either sulforaphane-cysteine (SFN …

Objective This study aims to investigate the apoptotic effect of Doxorubicin and its nano-
formulated form (Doxil) on oral squamous cell carcinoma CAL-27 cells. Design Cell viability …

The simultaneous sensing of endogenous wild and mutant proteins plays a critical role in
disease diagnosis and drug screening, and this remains a major current challenge. Here …

X‑linked inhibitor of apoptosis (XIAP), a key member of the inhibitors of apoptosis protein
family, can inhibit apoptosis by directly binding to the initiator caspase‑9,‑3 and‑7, thereby …

Even today, breast cancer remains a global public problem, with a high mortality rate among
women. Nanoparticle (NP) based systems are developed to enhance drug delivery …

Background: Associating paclitaxel (PTX) to doxorubicin (DXR) is one of the main
chemotherapy strategies for breast cancer (BC) management. Protocols currently available …